Healthcare & Medical Devices Global On demand · 24-48h

Global CBCT-guided Linear Accelerator (CBCT-Linac) Market Strategic Research Report

Global CBCT-guided Linear Accelerator (CBCT-Linac) Market St…
$3,500 USD
Market Research Reports
Strategic Research Report
Global CBCT-guided Linear Accelerator (CBCT-Linac) Market
$2.86B2025
14.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: C-arm CBCT-Linac, Ring-gantry CBCT-Linac

By Application: General-purpose Precision Radiotherapy, SBRT/SRS-focused Radiotherapy, Pelvic / Abdominal Adaptive Radiotherapy, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Elekta, Siemens Healthineers, Neusoft Medical, Shanghai United Imaging Healthcare Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 82 pages
Market size 2025
$2.86B
Billion USD
Forecast CAGR
14.7%
2025-2032
Forecast 2032
$7.5B
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global CBCT-guided Linear Accelerator (CBCT-Linac) market size is predicted to grow from US$ 2,861 million in 2025 to US$ 6,981 million in 2032; it is expected to grow at a CAGR of 14.7% from 2026 to 2032.

In 2025, the global sales volume of CBCT-guided Linear Accelerator (CBCT-Linac) reached approximately 975 units.The mainstream transaction price range was USD 2.24–3.75 million per unit, with an average industry gross margin of about 37%.CBCT-guided Linear Accelerator (CBCT-Linac) is a high-end radiotherapy device that organically integrates a Cone-Beam Computed Tomography (CBCT) system with a radiotherapy linear accelerator. Its core function is to complete real-time image positioning of patients before and during treatment through the on-board CBCT, accurately matching the tumor target area with the treatment coordinate system, and providing image-guided support for radiotherapy. Without the need for additional independent CT equipment, it can quickly obtain images of the patient's anatomical structure, correct positional errors, ensure that radiotherapy rays are accurately delivered to the tumor area, and maximize the protection of surrounding normal tissues. Equipped with various treatment technologies such as Volumetric Modulated Arc Therapy and Stereotactic Radiotherapy, this device has the advantages of convenient operation and efficient positioning, serving as one of the mainstream devices for clinical precision radiotherapy, mainly applied in routine and precision radiotherapy scenarios for various solid tumors.

Global key CBCT-guided Linear Accelerator (CBCT-Linac) players cover Elekta, Siemens Healthineers, Neusoft Medical, Shanghai United Imaging Healthcare Co., Ltd., etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global CBCT-guided Linear Accelerator (CBCT-Linac) market?

What factors are driving CBCT-guided Linear Accelerator (CBCT-Linac) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do CBCT-guided Linear Accelerator (CBCT-Linac) market opportunities vary by end market size?

How does CBCT-guided Linear Accelerator (CBCT-Linac) break out by Type, by Application?

This report presents a comprehensive overview of the global CBCT-guided Linear Accelerator (CBCT-Linac) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • C-arm CBCT-Linac
  • Ring-gantry CBCT-Linac

Segment by Imaging Performance Tier

  • Standard CBCT-Linac
  • Enhanced / Iterative CBCT-Linac
  • AI-enhanced High-performance CBCT-Linac

Segment by Adaptive Workflow Capability

  • IGRT-focused CBCT-Linac
  • Offline-adaptive CBCT-Linac
  • Online-adaptive CBCT-Linac

Segment by Application

  • General-purpose Precision Radiotherapy
  • SBRT/SRS-focused Radiotherapy
  • Pelvic / Abdominal Adaptive Radiotherapy
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global CBCT-guided Linear Accelerator (CBCT-Linac) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in General-purpose Precision Radiotherapy, SBRT/SRS-focused Radiotherapy, Pelvic / Abdominal Adaptive Radiotherapy evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global CBCT-guided Linear Accelerator (CBCT-Linac) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 14.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$2.86B
2025
Forecast
$7.5B
2032
CAGR
14.7%
2025–2032
リージョン
5
global
Key companies
ElektaSiemens HealthineersNeusoft MedicalShanghai United Imaging Healthcare Co., Ltd.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
C-arm CBCT-LinacRing-gantry CBCT-Linac
By Application
General-purpose Precision RadiotherapySBRT/SRS-focused RadiotherapyPelvic / Abdominal Adaptive RadiotherapyOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 C-arm CBCT-Linac
  • 3.1.3 Ring-gantry CBCT-Linac
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 General-purpose Precision Radiotherapy
  • 4.1.3 SBRT/SRS-focused Radiotherapy
  • 4.1.4 Pelvic / Abdominal Adaptive Radiotherapy
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Elekta
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Siemens Healthineers
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Neusoft Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Shanghai United Imaging Healthcare Co., Ltd.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global CBCT-guided Linear Accelerator (CBCT-Linac) market?
The global CBCT-guided Linear Accelerator (CBCT-Linac) market is estimated at US$ 2.86 billion in 2025 (base year) and is projected to reach US$ 6.98 billion by 2032.
How fast is the CBCT-guided Linear Accelerator (CBCT-Linac) market expected to grow?
The market is expected to grow at a CAGR of 14.7% from 2026 to 2032, expanding from US$ 2.86 billion in 2025 to US$ 6.98 billion in 2032, roughly 2.4 times its base-year value.
What does the CBCT-guided Linear Accelerator (CBCT-Linac) market cover?
In 2025, the global sales volume of CBCT-guided Linear Accelerator (CBCT-Linac) reached approximately 975 units.The mainstream transaction price range was USD 2.24–3.75 million per unit, with an average industry gross margin of about 37%.CBCT-guided Linear Accelerator (CBCT-Linac) is a high-end radiotherapy device that organically integrates a Cone-Beam Computed Tomography (CBCT) system with a radiotherapy linear accelerator.
How is the CBCT-guided Linear Accelerator (CBCT-Linac) market segmented by type?
By type, the market is segmented into C-arm CBCT-Linac and Ring-gantry CBCT-Linac.
What are the key applications of CBCT-guided Linear Accelerator (CBCT-Linac)?
Key applications covered include General-purpose Precision Radiotherapy, SBRT/SRS-focused Radiotherapy, Pelvic / Abdominal Adaptive Radiotherapy and Others.
Which companies are profiled in the CBCT-guided Linear Accelerator (CBCT-Linac) market report?
Key players profiled include Elekta, Siemens Healthineers, Neusoft Medical and Shanghai United Imaging Healthcare Co..
What geographies does the CBCT-guided Linear Accelerator (CBCT-Linac) market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for CBCT-guided Linear Accelerator (CBCT-Linac)?
What factors are driving CBCT-guided Linear Accelerator (CBCT-Linac) market growth, globally and by region?
Who should buy the CBCT-guided Linear Accelerator (CBCT-Linac) market report?
The report is intended for manufacturers and solution providers, distributors and end users in General-purpose Precision Radiotherapy, SBRT/SRS-focused Radiotherapy and Pelvic / Abdominal Adaptive Radiotherapy, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the CBCT-guided Linear Accelerator (CBCT-Linac) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.